首页> 外文期刊>BMC Oral Health >The efficacy of chlorhexidine gel in the prevention of alveolar osteitis after mandibular third molar extraction: a systematic review and meta-analysis
【24h】

The efficacy of chlorhexidine gel in the prevention of alveolar osteitis after mandibular third molar extraction: a systematic review and meta-analysis

机译:氯己定凝胶预防下颌第三磨牙摘除后牙槽骨炎的疗效:系统评价和荟萃分析

获取原文
获取外文期刊封面目录资料

摘要

Background Alveolar osteitis is a very painful and distressing condition for a patient who has recently undergone a tooth extraction and has led dental professionals to search for preventive measures. The aim of this meta-analysis to determine the effect of chlorhexidine (CHX) gel on the incidence of alveolar osteitis after mandibular third molar extraction. Methods Studies were searched for on electronic search engines using Medline (PubMed), Cochrane central, Scopus and advanced Google Scholar from May 2015 to December 2015. Randomized controlled trial studies with a history of mandibular third molar extraction, along with the administration of topical chlorhexidine gel were included. The risk of bias of the selected articles was assessed using the Cochrane risk of bias assessment tool. RevMan 5.3 Software was used to analyze the pooled effect. I2 was calculated to determine heterogeneity and a funnel plot was used to check the risk of bias. Subgroup analysis was also done based on the presence of confounding factors (smoking, oral contraceptive etc.) and on split mouth design. Results Out of 52 articles, ten met the inclusion criteria. 862 participants were involved in the selected studies with a mean age range from 24.15?±?5.02 to 36.65?±?11. The overall RR was 0.43 (95% CI: 0.32, 0.58, p 2) was 40%. The funnel plot showed that there was no significant publication bias. Conclusion This meta-analysis suggests that CHX gel is superior to a placebo in reducing the incidence of alveolar osteitis after mandibular third molar extraction.
机译:背景技术对于最近接受拔牙并导致牙科专业人员寻求预防措施的患者,肺泡性骨炎是一种非常痛苦和令人痛苦的疾病。这项荟萃分析的目的是确定洗必泰(CHX)凝胶对下颌第三磨牙摘除后牙槽骨炎发生率的影响。方法自2015年5月至2015年12月,使用Medline(PubMed),Cochrane Central,Scopus和进阶Google Scholar在电子搜索引擎上进行研究。具有下颌第三磨牙摘除史以及局部洗必泰给药的随机对照试验研究包括凝胶。使用Cochrane偏倚风险评估工具评估了选定商品的偏倚风险。 RevMan 5.3软件用于分析合并效果。计算I 2 以确定异质性,并使用漏斗图检查偏差的风险。还根据混杂因素(吸烟,口服避孕药等)的存在和口裂设计进行了亚组分析。结果在52篇文章中,有10篇符合纳入标准。 862名参与者参与了所选研究,平均年龄范围为24.15±5.02至36.65±11。总体RR为0.43(95%CI:0.32,0.58,p 2 )为40%。漏斗图显示没有明显的出版偏倚。结论这项荟萃分析表明,CHX凝胶在降低下颌第三磨牙拔除后牙槽骨炎的发生率方面优于安慰剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号